January 19, 2024 · Form 4 insider transaction
Peraza Lisa bought 6,846 shares of Heron Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).